Low 24-hour adiponectin and high nocturnal leptin concentrations in a case-control study of community-dwelling premenopausal women with major depressive disorder: The Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression (POWER) study

Journal of Clinical Psychiatry

Volumn 71, Issue 8, 2010, Pages 1079-1087

  Cizza, Giovanni ^a   Nguyen, Vi T ^a,b   Eskandari, Farideh ^c   Duan, Zhigang ^a   Wright, Elizabeth C ^a   Reynolds, James C ^d   Ahima, Rexford S ^e   Blackman, Marc R ^f,g  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALENDRONIC ACID; AMFEBUTAMONE; CORTICOTROPIN; HYDROCORTISONE; LEPTIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CIRCADIAN RHYTHM; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; OBESITY; OSTEOPENIA; OSTEOPOROSIS; OUTCOME ASSESSMENT; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPONECTIN; ADRENOCORTICOTROPIC HORMONE; ADULT; ALENDRONATE; BODY MASS INDEX; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS, TYPE 2; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; HYDROCORTISONE; LEPTIN; MIDDLE AGED; OSTEOPOROSIS; PREMENOPAUSE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; WOMEN'S HEALTH;

EID: 77955989541     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09m05314blu     Document Type: Article

References (45)

1. Evans DL, Charney DS, Lewis L, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry. 2005;58(3):175-189.
2. Ahima RS, Qi Y, Singhal NS, et al. Brain adipocytokine action and metabolic regulation. Diabetes. 2006;55(suppl 2):S145-S154.
3. Eskandari F, Martinez PE, Torvik S, et al. Premenopausal, Osteoporosis Women, Alendronate, Depression (POWER) Study Group. Low bone mass in premenopausal women with depression. Arch Intern Med. 2007;167(21):2329-2336.
4. Eskandari F, Mistry S, Martinez PE, et al. POWER (Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression) Study Group. Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: implications for greater cardiovascular risk. Metabolism. 2005;54(7):918-924.
5. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992;267(9):1244-1252.
6. Young EA, Veldhuis JD. Disordered adrenocorticotropin secretion in women with major depression. J Clin Endocrinol Metab. 2006;91(5):1924-1928.
7. Kessler RC, McGonagle KA, Zhao SY, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8-19.
8. Zhang YY, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425-432. doi:10.1038/372425a0 PubMed (Pubitemid 24365442)
9. Robertson SA, Leinninger GM, Myers MG Jr. Molecular and neural mediators of leptin action. Physiol Behav. 2008;94(5):637-642.
10. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature. 1996;382(6588):250-252. doi:10.1038/38250a0 PubMed (Pubitemid 26251358)
11. Heiman ML, Ahima RS, Craft LS, et al. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology. 1997;138(9):3859-3863.
12. Iwamoto I, Douchi T, Kosha S, et al. Relationships between serum leptin level and regional bone mineral density, bone metabolic markers in healthy women. Acta Obstet Gynecol Scand. 2000;79(12):1060-1064.
13. Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270(45):26746- 26749.
14. Psilopanagioti A, Papadaki H, Kranioti EF, et al. Expression of adiponectin and adiponectin receptors in human pituitary gland and brain. Neuroendocrinology. 2009;89(1):38-47.
15. Rodriguez-Pacheco F, Martinez-Fuentes AJ, Tovar S, et al. Regulation of pituitary cell function by adiponectin. Endocrinology. 2007;148(1):401-410. doi:10.1210/en.206-1019 PubMed (Pubitemid 46023452)
16. Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 2002;360(9326):57-58.
17. Snehalatha C, Mukesh B, Simon M, et al. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care. 2003;26(12):3226-3229. doi:10.237/diacare.26.12.326 PubMed (Pubitemid 37466879)
18. Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A. 2001;98(4):2005-2010.
19. Iwashima Y, Katsuya T, Ishikawa K, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension. 2004;43(6):1318-1323.
20. Hopkins TA, Ouchi N, Shibata R, et al. Adiponectin actions in the cardiovascular system. Cardiovasc Res. 2007;74(1):11-18.
21. Friedman JM. Leptin at 14 y of age: an ongoing story. Am J Clin Nutr. 2009;89(3):973S-979S.
22. Cizza G, Primma S, Csako G. Depression as a risk factor for osteoporosis. Trends Endocrinol Metab. 2009;20(8):367-373.
23. Licinio J, Mantzoros C, Negrão AB, et al. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med. 1997;3(5):575-579. doi:10.1038/nm0597-575 PubMed (Pubitemid 27198660)
24. Gavrila A, Peng CK, Chan JL, et al. Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. J Clin Endocrinol Metab. 2003;88(6):2838-2843.
25. Leo R, Di Lorenzo G, Tesauro M, et al. Decreased plasma adiponectin concentration in major depression. Neurosci Lett. 2006;407(3):211-213. doi:10.1016/j.neulet.206.08.043 PubMed (Pubitemid 44402873)
26. Hung YJ, Hsieh CH, Chen YJ, et al. Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder. Clin Endocrinol (Oxf). 2007;67(5):784-789.
27. First MB, Spitzer RL, Gibbon M, et al: Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P), Version 2.0. New York, NY: Biometrics Research, New York State Psychiatric Institute; August 1998.
28. Turner RC, Holman RR, Matthews D, et al. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism. 1979;28(11):1086-1096.
29. Lim S, Koo BK, Cho SW, et al. Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean atherosclerosis study (KAS): a 42-month prospective study. Atherosclerosis. 2008;196(1):398-404.
30. Pan A, Ye X, Franco OH, et al. The association of depressive symptoms with inflammatory factors and adipokines in middle-aged and older Chinese. PLoS ONE. 2008;3(1):e1392.
31. Narita K, Murata T, Hamada T, et al. Adiponectin multimer distribution, not absolute amount of plasma, correlates with depression severity in healthy elderly subjects. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(1):124-127.
32. Cizza G, Eskandari F, Coyle M, et al. Plasma CRP Levels in Premenopausal Women with Major Depression: a 12-Month Controlled Study. Horm Metab Res. 2009;41(8):641-648.
33. Cizza G, Marques AH, Eskandari F, et al. POWER Study Group. Elevated neuroimmune biomarkers in sweat patches and plasma of premenopausal women with major depressive disorder in remission: the POWER study. Biol Psychiatry. 2008;64(10):907-911.
34. Narita K, Murata T, Takahashi T, et al. Plasma levels of adiponectin and tumor necrosis factor-alpha in patients with remitted major depression receiving long-term maintenance antidepressant therapy. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(6):1159-1162. doi:10.1016/j.pnpbp.206.03.030 PubMed (Pubitemid 43928220)
35. Calvani M, Scarfone A, Granato L, et al. Restoration of adiponectin pulsatility in severely obese subjects after weight loss. Diabetes. 2004; 53(4):939-947.
36. Yildiz BO, Suchard MA, Wong ML, et al. Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad Sci U S A. 2004;101(28):10434-10439. doi:10.1073/pnas.0403465101 PubMed (Pubitemid 38924943)
37. Ohayon MM. Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. J Psychiatr Res. 1997;31(3):333-346.
38. Williams CJ, Hu FB, Patel SR, et al. Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes. Diabetes Care. 2007;30(5):1233-1240.
39. Shea SA, Hilton MF, Orlova C, et al. Independent circadian and sleep/wake regulation of adipokines and glucose in humans. J Clin Endocrinol Metab. 2005;90(5):2537-2544.
40. Gold PW, Wong ML, Goldstein DS, et al. Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci U S A. 2005;102(23):8303-8308.
41. Hassager C, Risteli J, Risteli L, et al. Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women. J Bone Miner Res. 1992;7(11):1307-1311.
42. Young EA, Carlson NE, Brown MB. Twenty-four-hour ACTH and cortisol pulsatility in depressed women. Neuropsychopharmacology. 2001;25(2):267-276.
43. Young EA, Haskett RF, Murphy-Weinberg V, et al. Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry. 1991;48(8):693-699.
44. Krishnamurthy P, Romagni P, Torvik S, et al. P.O.W.E.R. (Premenopausal, Osteoporosis Women, Alendronate, Depression) Study Group. Glucocorticoid receptor gene polymorphisms in premenopausal women with major depression. Horm Metab Res. 2008;40(3):194-198.
45. Hasin DS, Goodwin RD, Stinson FS, et al. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005; 62(10):1097-1106. (Pubitemid 41396935)